MATTHEW W JACKSON

Allopathic & Osteopathic Physicians|Internal Medicine BRONX, NY NPI 1497014351

General Payments — all program years on this page

$1,643.20

  • Category: General Payments
  • Program years: PY2019–2024
  • Record count: 91
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $381.07 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $381.0717

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2019 $30.112
2020 $122.722
2021 $177.399
2022 $282.4215
2023 $649.4946
2024 $381.0717

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086123906 Bayer Healthcare Pharmaceuticals Inc. $22.11 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086979616 Novartis Pharmaceuticals Corporation $23.22 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086979634 Novartis Pharmaceuticals Corporation $18.93 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086979644 Novartis Pharmaceuticals Corporation $17.63 06/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086979674 Novartis Pharmaceuticals Corporation $15.86 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086979682 Novartis Pharmaceuticals Corporation $27.74 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089436850 Daiichi Sankyo Inc. $26.11 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104312846 AstraZeneca Pharmaceuticals LP $26.51 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104433257 AstraZeneca Pharmaceuticals LP $24.85 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115777124 GlaxoSmithKline, LLC. $20.09 08/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115926800 GlaxoSmithKline, LLC. $20.98 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116291502 GlaxoSmithKline, LLC. $16.89 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116451219 GlaxoSmithKline, LLC. $20.71 04/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135170716 Lilly USA, LLC $34.06 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135170718 Lilly USA, LLC $28.30 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151075736 Phathom Pharmaceuticals, Inc. $22.02 10/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151075738 Phathom Pharmaceuticals, Inc. $15.06 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.